GW Pharmaceuticals Releases a Q4 Revenue Beat, but Will the Rapid Growth Continue? Scott Willis·January 13, 2020GW Pharmaceuticals' (NASDAQ: GWPH) 7% revenue beat was cheered by the markets, but with revenue growth slowing can...Marijuana News·0 Comments·
